author-photo

D Tudor

Takeda Pharmaceutical Company

8

Papers

11

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn’s Disease: A Post Hoc Analysis of GEMINI 2 and 3

2019 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (8)
P422 Sustained corticosteroid-free remission with vedolizumab in moderate-to-severe ulcerative colitis: A post hoc analysis of GEMINI 1

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
P738 Sustained clinical remission with vedolizumab in Moderate-to-Severe Crohn’s disease: A GEMINI 2 post hoc analysis of Week 14 remitters

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
Mo1808 - Improvements in Subcomponents of the Inflammatory Bowel Disease Questionnaire in Patients Treated with Vedolizumab: Results from Gemini Trial Data

2018 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
DOP054 Vedolizumab in combination with steroids for induction therapy in Crohn’s disease: an exploratory analysis of the GEMINI 2 and GEMINI 3 studies

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (2)